Dupilumab in atopic dermatitis patients with chronic hepatitis B

Masako Matsutani, Yasutomo Imai, Minori Nakatani‐Kusakabe, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa

Open source

DOI
10.1002/cia2.12209
Published
2021-09-30
Container
Journal of Cutaneous Immunology and Allergy
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cia2.12209,
  title = {Dupilumab in atopic dermatitis patients with chronic hepatitis B},
  author = {Masako Matsutani and Yasutomo Imai and Minori Nakatani‐Kusakabe and Masaru Natsuaki and Kiyofumi Yamanishi and Nobuo Kanazawa},
  year = {2021},
  journal = {Journal of Cutaneous Immunology and Allergy},
  doi = {10.1002/cia2.12209},
  url = {https://doi.org/10.1002/cia2.12209}
}

RIS

TY  - JOUR
TI  - Dupilumab in atopic dermatitis patients with chronic hepatitis B
AU  - Masako Matsutani
AU  - Yasutomo Imai
AU  - Minori Nakatani‐Kusakabe
AU  - Masaru Natsuaki
AU  - Kiyofumi Yamanishi
AU  - Nobuo Kanazawa
PY  - 2021
JO  - Journal of Cutaneous Immunology and Allergy
DO  - 10.1002/cia2.12209
UR  - https://doi.org/10.1002/cia2.12209
ER  - 

APA

Matsutani, M., Imai, Y., Nakatani‐Kusakabe, M., Natsuaki, M., Yamanishi, K., & Kanazawa, N. (2021). Dupilumab in atopic dermatitis patients with chronic hepatitis B. Journal of Cutaneous Immunology and Allergy. https://doi.org/10.1002/cia2.12209

Source records